Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD19-targeting CAR T-cell Therapy for R/R B-cell ALL
NCT03919240Phase 2Active, not recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Dec 2015
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in acute lymphoblastic leukemia (ALL) (3 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoints: Complete Remission at 1 month, Minimal Residual Disease Response at 1 month and 1 more. Started Dec 2015; status: active, not recruiting.
02
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT03919240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03919240.